TLSA - Tiziana Life Sciences PLC

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
105.69M
Enterprise Value 3
43.49M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 1.11
52-Week Change 3∞%
S&P500 52-Week Change 38.78%
52 Week High 312.17
52 Week Low 33.34
50-Day Moving Average 35.97
200-Day Moving Average 37.08

Share Statistics

Avg Vol (3 month) 38.2k
Avg Vol (10 day) 314.91k
Shares Outstanding 513.65M
Float 5.01M
% Held by Insiders 10.00%
% Held by Institutions 12.82%
Shares Short (Sep 30, 2019) 46.27k
Short Ratio (Sep 30, 2019) 42.74
Short % of Float (Sep 30, 2019) 4N/A
Short % of Shares Outstanding (Sep 30, 2019) 40.26%
Shares Short (prior month Aug 30, 2019) 4883

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Oct 29, 2019

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-267.52%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.31
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A